Last updated on July 2019

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells


Brief description of study

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study.

Subjects who received at least one GM T cell infusion, will be asked to roll-over to this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.

Detailed Study Description

Subjects participating in this study will be followed from time of roll-over from the parent GM T protocol until 15 years after the last GMT infusion, withdrawal of consent, lost to follow-up, or death, whichever occurs first. Both local and central laboratory evaluations and safety assessments will be conducted during this trial. In addition, pediatric subjects will be monitored for growth, development and sexual maturity.

Stage 5 per Tanner Staging Criteria must be reached prior to study discontinuation.

Clinical Study Identifier: NCT03435796

Find a site near you

Start Over

Mayo Clinic Phoenix

Phoenix, AZ United States
  Connect »

City of Hope

Duarte, CA United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

UCLA Medical Centre-Santa Monica

Santa Monica, CA United States
  Connect »

Stanford Cancer Center

Stanford, CA United States
  Connect »

Northside Hospital, Inc

Atlanta, GA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

IN Univ Simon Cancer Center

Indianapolis, IN United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

National Cancer Institute

Bethesda, MD United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Siteman Cancer Center

Saint Louis, MO United States
  Connect »

Regional Cancer Care Associates LLC

East Brunswick, NJ United States
  Connect »

Morristown Memorial Hosp

Morristown, NJ United States
  Connect »

Levine Cancer Institute

Charlotte, NC United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

UPMC Cancer Pavillion

Pittsburgh, PA United States
  Connect »

Sarah Cannon Research Inst

Nashville, TN United States
  Connect »

SAM Clinical Research Center

San Antonio, TX United States
  Connect »

Swedish Cancer Institute

Seattle, WA United States
  Connect »

UZ Gent

Gent, Belgium
  Connect »

Institut Paoli-Calmettes

Marseille Cedex 9, France
  Connect »

H pitaux de La Timone

Marseille Cedex 9, France
  Connect »

CHU Hotel Dieu

Nantes Cedex 01, France
  Connect »

Centre Hospitalier Lyon-Sud

Pierre-Benite CEDEX, France
  Connect »

CHU La Miletrie

Poitiers Cedex, France
  Connect »

Kings College Hospital

London, United Kingdom
  Connect »

UCL Cancer Institute

London, United Kingdom
  Connect »

Christie Hospital NHS Trust

Manchester Withington, United Kingdom
  Connect »

Somers Cancer Research Building

Shirley Southampton, United Kingdom
  Connect »

Tokai University Hospital

Isehara City, Kanagawa, Japan
  Connect »

Arizona Cancer Center

Scottsdale, AZ United States
  Connect »

Oncology Hematology Care, Inc.

Cincinnati, OH United States
  Connect »

University Of Wisconsin

Madison, WI United States
  Connect »